A comparability study of 5 commercial KRAS tests

BACKGROUND: Activating mutations in the KRAS gene occur frequently in human tumors, including colorectal carcinomas; most mutations occur in codons 12 and 13. Mutations in KRAS have been associated with poor response to anti-epidermal growth factor receptor antibodies. Therefore, an accurate and rea...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliner, Kelly, Juan, Todd, Suggs, Sid, Wolf, Michael, Sarosi, Ildiko, Freeman, Daniel J, Gyuris, Tibor, Baron, Will, Bakker, Andreas, Parker, Alex, Patterson, Scott D
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2879238/
https://www.ncbi.nlm.nih.gov/pubmed/20398393
http://dx.doi.org/10.1186/1746-1596-5-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2879238/
https://www.ncbi.nlm.nih.gov/pubmed/20398393
http://dx.doi.org/10.1186/1746-1596-5-23

Ejemplares similares